China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Consistency comparison of PD-L1 antibody reagents WD160 and 22C3'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136755
Registration Time: 2026/11/15
Type: Observational study
Primary Sponsor: Zhejiang Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=328415
Published by HT Digital Content Services with permission from Health Daily Digest....